Annual Evaluation Report on the "Corporate Value and Return Enhancement" Action Plan 2025 and the "Corporate Value and Return Enhancement" Action Plan 2026

About this update from Jiangxi Tianxin Pharmaceutical Co., Ltd. Class A

Annual Evaluation Report on the "Corporate Value and Return Enhancement" Action Plan 2025 and the "Corporate Value and Return Enhancement" Action Plan 2026 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangxi Tianxin Pharmaceutical Co., Ltd. Class A